<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">REMEDIUM</journal-id><journal-title-group><journal-title>REMEDIUM</journal-title></journal-title-group><issn publication-format="print">1561-5936</issn><issn publication-format="electronic">2658-3534</issn><publisher><publisher-name>Joint-Stock Company Chicot</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1129</article-id><article-id pub-id-type="doi">10.21518/1561-5936-2019-9-48-51</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Combination of private and public interests in the legal regulation of gene technologies</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Mokhov</surname><given-names>А. А.</given-names></name><bio></bio><email>noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yavorskiy</surname><given-names>A. N.</given-names></name><bio></bio><email>noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff id="aff-1">Kutafin Moscow State Law University (MSAL)</aff><aff id="aff-2">Pushchino State Institute of Natural Science</aff><pub-date date-type="epub" iso-8601-date="2019-12-09" publication-format="electronic"><day>09</day><month>12</month><year>2019</year></pub-date><issue>9</issue><fpage>48</fpage><lpage>51</lpage><history><pub-date date-type="received" iso-8601-date="2022-03-18"><day>18</day><month>03</month><year>2022</year></pub-date></history><permissions><copyright-statement>Copyright © 2019,</copyright-statement><copyright-year>2019</copyright-year></permissions><abstract>The development of genetic technologies, the implementation of a biomedical project in the country, the transition of public health service to the principles of 4 Ps - such are modern trends. Consequently, the question of the day is the formation of legislation regulating the scientific, innovative, medical and other areas, where gene technologies can be actively used. This requires the development of the foundations and principles of their legal regulation, including the principle for combining private and public interests. In the future, legislation regulating gene technologies will be formed based on the definition of the pool of participants in this process, their interests that are necessary for this area of permissions, obligations and prohibitions.</abstract><kwd-group xml:lang="en"><kwd>biomedicine</kwd><kwd>biomedical project</kwd><kwd>gene technologies</kwd><kwd>private and public interests</kwd><kwd>legal regulation</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>биомедицина</kwd><kwd>биомедицинский проект</kwd><kwd>генетические технологии</kwd><kwd>частные и публичные интересы</kwd><kwd>правовое регулирование</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Быков П., Шарапов С. Нас накрывает генетический шторм. Эксперт. 2019;(4). Режим доступа: https://expert.ru/expert/2019/04/ nas-nakryivaet-geneticheskij-shtorm/.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Курбатов А.Я. Сочетание частных и публичных интересов при правовом регулировании предпринимательской деятельности. М.: Юринфор, 2001. 212 с.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Берг Л.Н. Проблемы законодательного обеспечения научной деятельности в России. Актуальные проблемы российского права. 2015;(1):3-5.</mixed-citation></ref></ref-list></back></article>
